SCHEMBL6970979

SCHEMBL6970979

COC(=O)c1ccc(S(=O)(=O)Cl)c(C)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 1/20 0.49
ALDH1A1 P00352 9/20 0.48
KDM4E B2RXH2 5/20 0.48
HPGD P15428 4/20 0.48
GAA P10253 2/20 0.48
PKM P14618 1/20 0.48
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA14 Q9ULX7 2/20 0.47
XDH P47989 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
CYP2C9 P11712 5/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
TSHR P16473 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31587402 0.87 ALDH1A1 (0.50) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL669263 0.87 ALDH1A1 (0.50) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL12492782 0.85 VCAM1 (0.61) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL3164592 0.83 ALDH1A1 (0.54) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL22867134 0.83 CA1 (0.53) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL9324149 0.83 KDM4E (0.53) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL29948709 0.83 ALDH1A1 (0.54) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL3118833 0.82 ACLY (0.48) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL30545664 0.82 TRPV4 (0.58) VCAM1ALDH1A1KDM4EHPGDGAA
SCHEMBL9093802 0.82 TRPV4 (0.58) VCAM1ALDH1A1KDM4EHPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1109560-B1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2003-08-27 EP disclosed
US-6525050-B1 Inhibit the enzyme aminoimidazole carboxamide ribonucleotide formyl transferase; antiproliferative agents; antitumor, antiinflammatory, antipsoriatic, and/or immunosuppressive AGOURON PHARMACEUTICALS, INC. 2003-02-25 US disclosed
EP-1109560-A4 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMA (US) 2002-04-17 EP disclosed
EP-1109560-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2001-06-27 EP disclosed
WO-2000013688-A1 COMPOUNDS USEFUL AS AICARFT INHIBITORS AGOURON PHARMACEUTICALS, INC. (US) 2000-03-16 WO disclosed